Pharmacokinetics
486
19
23
379
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Published Results
82 trials with published results (17%)
Research Maturity
379 completed trials (78% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.9%
9 terminated out of 486 trials
97.7%
+11.1% vs benchmark
7%
33 trials in Phase 3/4
22%
82 of 379 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 379 completed trials
Clinical Trials (486)
Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)
Pharmacokinetics and Pharmacodynamics of Sugammadex Dosed by Corrected Body Weight for Reversal of Vecuronium in Obese Patients
Antibiotic Dosing in Pediatric Intensive Care
Tenofovir Exposures in Advanced Kidney Disease Study
A Randomized, Double-Blind, Positive-Controlled, Parallel Pharmacokinetic Phase I Clinical Study of Cetuximab Injection Versus Erbitux in Healthy Male Subjects
High Potency Cannabis: Acute and Protracted Effects
Pharmacokinetics of Kava and Kratom Alone and in Combination
Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Adults (18-55 Years)
Study of Metabolic Absorption Rates of DHA-Taurine as a Source of Omega-3 Fatty Acids
Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose
Safety and Pharmacokinetics (PK) Study of Natrunix in Healthy Volunteers
Pharmacokinetics of Oral Calcium Carbonate in Parturients
A First-in-Human SAD and MAD Study in Healthy Participants to Evaluate Oral YR011 Tablet
A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Healthy Adult Subjects
Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy Volunteers
To Evaluate the Safety, Tolerability, Pharmacokinetics and the Effect of Food on the Hemay5259 Sustained-release Tablets in Healthy Subjects.
Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
Scavenging of Reactive Carbonyl Species by Apple Polyphenols in Human
A Randomized, Multicenter, Open-label, Active-controlled Phase Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Multiple Intravaginal Doses of GenSci142 in Patients With Bacterial Vaginosis (BV)